Skip to main content
    A

    Alpha Teknova Inc (TKNO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.77
    -0.44 (-5.36%)

    Market Cap: $516.43M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Alpha Teknova Inc (TKNO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Alpha Teknova reported revenue of $40.52M for the fiscal year ended Dec 31, 2025, up 7.4% from the year before. That year, net income was -$17.26M with a net margin of -42.6%, operating cash flow was -$8.65M and free cash flow was -$9.79M. The quarter ended Sep 30, 2026 had revenue of $12.70M and net income of -$3.49M.

    Revenue and Margins

    The operating margin was -41.9% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $20.09M, a compound annual rate of 12.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$40.52M+7.4%33.2%-41.9%-42.6%
    Dec 2024$37.74M+2.9%19.2%-69.3%-70.9%
    Dec 2023$36.68M-11.4%28.1%-96.9%-100.3%
    Dec 2022$41.42M+12.3%42.2%-119.9%-114.6%
    Dec 2021$36.89M+17.9%47.8%-32.5%-26.6%
    Dec 2020$31.30M+55.8%56.7%14.9%11.4%
    Dec 2019$20.09MN/A42.7%-9.2%-6.5%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$40.52M$37.74M$36.68M$41.42M$36.89M$31.30M$20.09M
    Cost of revenue$27.08M$30.51M$26.39M$23.94M$19.27M$13.54M$11.52M
    Gross profit$13.44M$7.23M$10.30M$17.48M$17.62M$17.75M$8.57M
    Research and development$2.20M$2.76M$5.57M$7.74M$4.31M$1.51M$769.00K
    Operating income-$16.98M-$26.15M-$35.56M-$49.66M-$12.01M$4.66M-$1.86M
    Net income-$17.26M-$26.75M-$36.78M-$47.47M-$9.80M$3.57M-$1.30M
    EBITDA-$10.54M-$19.52M-$29.26M-$46.16M-$9.03M$6.68M-$233.00K
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$12.70M$12.19M$11.08M$9.98M$10.45M$10.29M$9.79M$9.27M$9.58M$9.61M$9.29M$7.87M
    Gross profit$4.83M$4.88M$3.78M$3.24M$3.21M$3.98M$3.01M$2.13M$90.00K$2.80M$2.21M$1.33M
    Operating income-$3.21M-$2.89M-$4.30M-$4.61M-$4.02M-$3.39M-$4.96M-$5.63M-$7.43M-$5.10M-$7.99M-$10.86M
    Net income-$3.49M-$3.17M-$4.55M-$4.76M-$4.29M-$3.57M-$4.64M-$5.72M-$7.57M-$5.36M-$8.10M-$10.66M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $13.12M exceeded cash and equivalents by $7.21M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$103.58M$118.77M$128.59M$152.26M$166.51M$62.91M$58.51M
    Current assets$34.51M$42.78M$45.66M$61.14M$101.20M$16.41M$15.42M
    Cash and equivalents$5.91M$3.71M$28.48M$42.24M$87.52M$3.31M$4.14M
    Total liabilities$34.81M$36.38M$38.55M$52.38M$11.17M$10.51M$45.60M
    Short-term debt$0$4.04M$0$2.22M$200.00KN/A$45.00K
    Long-term debt$13.12M$9.44M$13.25M$21.98M$11.87M$0N/A
    Shareholder equity$68.78M$82.39M$90.04M$99.89M$143.20M$16.77M$12.91M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$94.68M$95.88M$98.66M$103.58M$107.63M$110.49M$113.99M$118.77M$124.10M$115.35M$120.82M$128.59M
    Total liabilities$34.90M$33.28M$33.73M$34.81M$34.98M$34.43M$35.39M$36.38M$36.83M$36.42M$37.44M$38.55M
    Cash and equivalents$6.63M$6.00M$4.31M$5.91M$3.20M$3.28M$3.38M$3.71M$6.14M$18.60M$21.60M$28.48M
    Shareholder equity$59.78M$62.60M$64.92M$68.78M$72.65M$76.06M$78.61M$82.39M$87.27M$78.93M$83.38M$90.04M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$8.65M-$12.39M-$18.81M-$27.40M-$9.07M$2.50M$2.17M
    Capital expenditures$1.15M$1.13M$7.93M$28.15M$19.88M$5.47M$2.65M
    Free cash flow-$9.79M-$13.52M-$26.75M-$55.55M-$28.95M-$2.96M-$477.00K
    Dividends paidN/AN/A$252.00KN/AN/AN/A$270.00K
    Investing cash flow$10.70M-$27.27M-$7.74M-$28.15M-$17.52M-$1.74M-$8.16M
    Financing cash flow$151.00K$14.89M$12.80M$10.27M$110.79M-$1.60M$8.57M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.28M-$471.00K-$3.36M-$462.00K-$1.98M-$2.10M-$4.10M-$936.00K-$2.06M-$2.84M-$6.56M-$2.89M
    Capital expenditures$120.00K$125.00K$221.00K$348.00K$387.00K$207.00K$206.00K$567.00K$331.00K$115.00K$112.00K$312.00K
    Free cash flow-$1.40M-$596.00K-$3.58M-$810.00K-$2.37M-$2.31M-$4.31M-$1.50M-$2.39M-$2.95M-$6.67M-$3.20M
    Last 12 quarters

    Frequently Asked Questions About TKNO

    What is Alpha Teknova's annual revenue?

    Alpha Teknova reported revenue of $40.52M for the fiscal year ended Dec 31, 2025.

    How fast is Alpha Teknova's revenue growing?

    Revenue was up 7.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.7%.

    Is Alpha Teknova profitable?

    No. Alpha Teknova reported net income of -$17.26M for the fiscal year ended Dec 31, 2025, with a net margin of -42.6%.

    How much free cash flow does TKNO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$8.65M minus capital expenditures of $1.15M produced free cash flow of -$9.79M.

    How much debt does Alpha Teknova have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $13.12M, short-term debt of $0 and cash and equivalents of $5.91M.